Norges Bank
RVMD icon

Norges Bank’s Revolution Medicines RVMD Stock Holding History

Norges Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404M Buy
+2,157,479
New +$315M 0.04% 355
2026
Q1 		– Sell
-2,455,347
Closed -$196M – 1131
2025
Q4 		$196M Buy
+2,455,347
New +$161M 0.02% 525
2025
Q3 		– Sell
-1,701,111
Closed -$62.6M – 1254
2025
Q2 		$62.6M Buy
1,701,111
+297,583
+21% +$11.4M 0.01% 861
2025
Q1 		$49.6M Sell
1,403,528
-338,511
-19% -$13.7M 0.01% 941
2024
Q4 		$76.2M Sell
1,742,039
-4,562
-0.3% -$230K 0.01% 789
2024
Q3 		$79.2M Sell
1,746,601
-102,046
-6% -$4.44M 0.01% 771
2024
Q2 		$71.7M Buy
1,848,647
+140,371
+8% +$5.25M 0.01% 761
2024
Q1 		$55.1M Buy
1,708,276
+1,426,571
+506% +$42.3M 0.01% 894
2023
Q4 		$8.08M Sell
281,705
-157,982
-36% -$3.8M ﹤0.01% 1561
2023
Q3 		$12.2M Buy
439,687
+72,200
+20% +$2.14M ﹤0.01% 1392
2023
Q2 		$9.83M Sell
367,487
-146,529
-29% -$3.6M ﹤0.01% 1539
2023
Q1 		$11.1M Sell
514,016
-108,625
-17% -$2.67M ﹤0.01% 1540
2022
Q4 		$14.8M Buy
622,641
+67,900
+12% +$1.44M ﹤0.01% 1406
2022
Q3 		$10.9M Buy
554,741
+62,734
+13% +$1.38M ﹤0.01% 1501
2022
Q2 		$9.59M Buy
492,007
+19,456
+4% +$379K ﹤0.01% 1571
2022
Q1 		$12.1M Buy
472,551
+13,508
+3% +$294K ﹤0.01% 1630
2021
Q4 		$11.6M Buy
459,043
+53,077
+13% +$1.5M ﹤0.01% 1712
2021
Q3 		$11.2M Buy
405,966
+319,400
+369% +$9.3M ﹤0.01% 1729
2021
Q2 		$2.75M Sell
86,566
-82,168
-49% -$2.87M ﹤0.01% 1973
2021
Q1 		$7.74M Buy
+168,734
New +$7.57M ﹤0.01% 1846
2020
Q3 		– Sell
-48,245
Closed -$1.52M – 2159
2020
Q2 		$1.52M Sell
48,245
-21,755
-31% -$684K ﹤0.01% 1987
2020
Q1 		$1.53M Buy
+70,000
New +$1.94M ﹤0.01% 1949

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Norges Bank's RVMD Position: Q2 2026 in Review

Norges Bank opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,157,479 shares worth $404M. The stake represents 0.04% of the portfolio and ranks #355 among its holdings. This is a return to the name: Norges Bank previously reported a position in RVMD as recently as Q4 2025.

Norges Bank first reported a position in RVMD in Q1 2020 and has held it in 22 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Norges Bank held 2,157,479 shares of Revolution Medicines worth $404M as of Q2 2026.
  • Revolution Medicines was a new Norges Bank position in Q2 2026.
  • Revolution Medicines made up 0.04% of Norges Bank's portfolio in Q2 2026, its #355 holding.
  • Norges Bank first reported a position in Revolution Medicines in Q1 2020 and has held it in 22 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.